Related Experiment Video
Updated: Jan 22, 2026

A Cognitive Paradigm to Investigate Interference in Working Memory by Distractions and Interruptions
Published on: July 16, 2015
Identifying an Optimal Cutoff of the Montreal Cognitive Assessment to Predict Amyloid-PET Positivity in a Referral
Anil K Nair1, Srinath Ramaswamy, Krystal Kan
1Alzheimer Disease Center, Quincy, MA.
Background:
Brain amyloid- positron emission tomography (PET) imaging is highly sensitive for identifying Alzheimer disease. Currently, there is a lack of insight on the association between amyloid-PET status and the widely used Montreal cognitive assessment (MoCA). Studying this relationship may optimize the clinical use of amyloid-PET imaging.
Objectives:
To evaluate the relationship between amyloid-PET status and MoCA scores and to identify a MoCA score cutoff that translates to amyloid-PET positivity.
Methods:
Using retrospective chart review, patients from 2010 to 2017 with amyloid-PET scans (positive or negative) and MoCA test scores were included. We studied the relationship between amyloid-PET status and MoCA scores and the influence of age, sex, education, and race. A MoCA score cutoff for amyloid-PET positivity was estimated.
Results:
Among the 684 clinic patients with dementia, 99 fulfilled inclusion criteria. Amyloid-PET positivity was associated significantly with lower MoCA scores (median=19, U=847, P=0.01). The MoCA score cutoff (25) used for minimal cognitive impairment (MCI) predicted amyloid-PET positivity suboptimally (sensitivity=94.6%, specificity=13.9%). A MoCA score cutoff of 20 patients had optimal sensitivity (64.2%) and specificity (67.4%).
Conclusions:
Amyloid-PET positivity is associated with lower MoCA scores. Clinical utility of amyloid-PET scan is likely to be suboptimal at the MoCA score cutoff for minimal cognitive impairment.
Insights
Brain amyloid-PET scans are linked to lower Montreal Cognitive Assessment (MoCA) scores. A MoCA cutoff of 20 offers better accuracy for predicting amyloid-PET positivity in dementia patients.
Area of Science:
- Neurology
- Radiology
- Cognitive Science
Background:
- Brain amyloid-PET imaging is a sensitive diagnostic tool for Alzheimer's disease.
- The relationship between amyloid-PET status and the Montreal Cognitive Assessment (MoCA) requires further investigation.
- Optimizing the clinical application of amyloid-PET imaging is crucial.
Purpose of the Study:
- To investigate the association between amyloid-PET scan results and MoCA scores.
- To determine an optimal MoCA score cutoff for predicting amyloid-PET positivity.
Main Methods:
- Retrospective chart review of patients with amyloid-PET scans and MoCA scores (2010-2017).
- Analysis of the relationship between amyloid-PET status and MoCA scores, considering age, sex, education, and race.
- Estimation of a MoCA score cutoff for predicting amyloid-PET positivity.
Main Results:
- Amyloid-PET positivity correlated significantly with lower MoCA scores (median=19, P=0.01).
- A MoCA cutoff of 25 (for MCI) showed suboptimal prediction of amyloid-PET positivity (sensitivity 94.6%, specificity 13.9%).
- A MoCA cutoff of 20 demonstrated improved prediction (sensitivity 64.2%, specificity 67.4%).
Conclusions:
- Lower MoCA scores are associated with amyloid-PET positivity.
- The standard MoCA cutoff for minimal cognitive impairment may limit the clinical utility of amyloid-PET scans.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Design Example: Identifying the Locations of Monuments in the Field Using Global Positioning System Device
Cognitive Dissonance
Predicting Molecular Geometry
Angina III: Clinical Manifestations and Assessment

